T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.1% |
| 2 | Technology | 17.78% |
| 3 | Consumer Discretionary | 15.32% |
| 4 | Financials | 14.61% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Wheaton Precious Metals
WPM
$59.9B
| $4.04M | ﹤0.01% |
231,087
-63,413
| -22% | -$1.22M |
|
1477
Ingredion
INGR
$6.54B
| $3.98M | ﹤0.01% |
37,918
+2,497
| +7% | +$255K |
|
1478
Toronto Dominion Bank
TD
$204B
| $3.93M | ﹤0.01% |
64,743
+2,529
| +4% | +$151K |
|
|
SYRS
1479
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.9M | ﹤0.01% |
32,721
-27
| -0.1% | -$3.13K |
|
1480
Ares Capital
ARCC
$14.5B
| $3.87M | ﹤0.01% |
225,000
| – | – |
|
1481
Autoliv
ALV
$8.85B
| $3.8M | ﹤0.01% |
43,868
-16,274
| -27% | -$1.55M |
|
1482
Compass Minerals
CMP
$1.12B
| $3.79M | ﹤0.01% |
56,470
-4,857
| -8% | -$317K |
|
1483
American Financial Group
AFG
$12B
| $3.77M | ﹤0.01% |
33,925
-1,247
| -4% | -$139K |
|
1484
Cartesian Therapeutics
RNAC
$262M
| $3.72M | ﹤0.01% |
7,966
+11
| +0.1% | +$4.42K |
|
1485
MakeMyTrip
MMYT
$5.67B
| $3.69M | ﹤0.01% |
134,327
+400
| +0.3% | +$12.8K |
|
|
CSOD
1486
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $3.68M | ﹤0.01% |
64,870
-274
| -0.4% | -$14.8K |
|
1487
Meritage Homes
MTH
$4.8B
| $3.65M | ﹤0.01% |
182,896
+60
| +0% | +$1.31K |
|
|
LINDW
1488
DELISTED
Lindblad Expeditions Holdings Inc. Warrant
LINDW
| $3.64M | ﹤0.01% |
886,585
| – | – |
|
1489
Howard Hughes
HHH
$4.04B
| $3.63M | ﹤0.01% |
30,633
-1,111
| -3% | -$140K |
|
1490
SPS Commerce
SPSC
$2.86B
| $3.62M | ﹤0.01% |
73,014
+20
| +0% | +$896 |
|
1491
National Healthcare
NHC
$3.47B
| $3.59M | ﹤0.01% |
47,641
+71
| +0.1% | +$5.22K |
|
|
RDS.A
1492
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $3.59M | ﹤0.01% |
52,700
| – | – |
|
|
LSXMA
1493
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.55M | ﹤0.01% |
113,031
+69
| +0.1% | +$2.31K |
|
1494
SiriusXM
SIRI
$9.43B
| $3.53M | ﹤0.01% |
55,846
-220,687
| -80% | -$15.4M |
|
|
DPLO
1495
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $3.5M | ﹤0.01% |
180,058
-214,824
| -54% | -$4.57M |
|
|
CIT
1496
DELISTED
CIT Group Inc.
CIT
| $3.48M | ﹤0.01% |
67,533
-9,824
| -13% | -$523K |
|
1497
Herbalife
HLF
$1.23B
| $3.43M | ﹤0.01% |
62,940
-2,680
| -4% | -$148K |
|
1498
Reinsurance Group of America
RGA
$16.1B
| $3.43M | ﹤0.01% |
23,740
+1,468
| +7% | +$208K |
|
1499
Trinity Industries
TRN
$2.3B
| $3.43M | ﹤0.01% |
130,105
+5,848
| +5% | +$153K |
|
1500
Diodes
DIOD
$4.48B
| $3.4M | ﹤0.01% |
102,078
-4,174
| -4% | -$151K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.